Xponance, Inc. Boston Scientific Corp Transaction History

Xponance, Inc.

$11.7 Billion
Q2 2025

A detailed history of Xponance, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Xponance, Inc. holds 257,608 shares of BSX stock, worth $25.5 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

257,608

Previous 217,839 18.26%

Holding current value

$25.5 Million

Previous $22 Million 25.91%

% of portfolio

0.24%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$89.7 - $107.41 $3.57 Million - $4.27 Million	39,769 Added 18.26%	257,608 $27.7 Million
Q1 2025 Apr 30, 2025	SELL	$89.38 - $106.18 $116,194 - $138,034	-1,300 Reduced 0.59%	217,839 $22 Million
Q4 2024 Feb 10, 2025	BUY	$83.62 - $91.5 $893,145 - $977,311	10,681 Added 5.12%	219,139 $19.6 Million
Q3 2024 Nov 12, 2024	BUY	$72.96 - $84.0 $309,861 - $356,748	4,247 Added 2.08%	208,458 $17.5 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $327,829 - $378,369	-4,869 Reduced 2.33%	204,211 $15.7 Million
Q1 2024 May 13, 2024	BUY	$57.6 - $68.62 $983,923 - $1.17 Million	17,082 Added 8.9%	209,080 $14.3 Million
Q4 2023 Jan 31, 2024	BUY	$48.64 - $57.81 $609,799 - $724,763	12,537 Added 6.99%	191,998 $11.1 Million
Q3 2023 Oct 23, 2023	BUY	$50.19 - $54.68 $410,604 - $447,337	8,181 Added 4.78%	179,461 $9.48 Million
Q2 2023 Jul 13, 2023	SELL	$49.72 - $54.64 $12,877 - $14,151	-259 Reduced 0.15%	171,280 $9.26 Million
Q1 2023 Apr 17, 2023	BUY	$45.09 - $50.03 $165,435 - $183,560	3,669 Added 2.19%	171,539 $8.58 Million
Q4 2022 Jan 23, 2023	BUY	$39.56 - $47.22 $1.01 Million - $1.21 Million	25,628 Added 18.02%	167,870 $0
Q3 2022 Oct 24, 2022	BUY	$36.71 - $109.66 $834,234 - $2.49 Million	22,725 Added 19.01%	142,242 $5.51 Million
Q2 2022 Aug 02, 2022	BUY	$35.24 - $47.1 $812,141 - $1.09 Million	23,046 Added 23.89%	119,517 $4.45 Million
Q1 2022 Apr 20, 2022	BUY	$40.9 - $45.1 $174,193 - $192,080	4,259 Added 4.62%	96,471 $4.27 Million
Q4 2021 Jan 31, 2022	BUY	$38.07 - $44.87 $780,016 - $919,341	20,489 Added 28.57%	92,212 $3.92 Million
Q3 2021 Nov 05, 2021	SELL	$41.23 - $45.88 $272,901 - $303,679	-6,619 Reduced 8.45%	71,723 $3.11 Million
Q2 2021 Aug 12, 2021	BUY	$38.58 - $44.24 $679,432 - $779,110	17,611 Added 29.0%	78,342 $3.35 Million
Q1 2021 May 10, 2021	SELL	$35.27 - $39.67 $43,170 - $48,556	-1,224 Reduced 1.98%	60,731 $2.35 Million
Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $128,224 - $162,339	3,868 Added 6.66%	61,955 $2.23 Million
Q3 2020 Oct 26, 2020	SELL	$34.44 - $42.23 $6,612 - $8,108	-192 Reduced 0.33%	58,087 $2.22 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $1.76 Million - $2.28 Million	58,279 New	58,279 $2.05 Million

Others Institutions Holding BSX

# of Institutions

1,936

Shares Held

1.27B

Call Options Held

9.55M

Put Options Held

7.11M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $142B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account